Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa
Authors:
Open Access
- 1 July 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (7) , 1466-1469
Abstract
Twenty-eight strains of Pseudomonas aeruginosa with various degrees of norfloxacin resistance were isolated from patients with urinary tract infections. P. aeruginosa strains (norfloxacin MICs, 3.13 to 200 micrograms/ml) were transformed by either pPAW207 or pNF111 plasmid DNA, which included either the gyrA or nfxB gene, respectively. For transformants with pPAW207, norfloxacin MICs decreased 8- to 128-fold. It was suggested that moderate and high degrees of resistance to norfloxacin were expressed as a result of alterations in gyrA. No strain manifesting only an alteration in nfxB permeability was observed. The MICs of norfloxacin (200 micrograms/ml) for two P. aeruginosa strains, GN17605 and GN17434-2, were decreased following transformation not only by pPAW207 but also by pNF111. Analysis of outer membrane proteins disclosed the presence of a 54,000-Da protein in these parent strains that was not expressed in the pNF111 transformants. The level of accumulation of norfloxacin by the pNF111 transformant of GN17605 was higher than that by the parent strain. The norfloxacin susceptibility of DNA gyrase subunit A purified from GN17605 was only 1/35th that of the gyrase containing a subunit A from P. aeruginosa PAO1. These findings suggest that GN17605 is a gyrA-nfxB double mutant and that strain GN17434-2 possesses double mutations in both nfxB and some unknown gene.Keywords
This publication has 18 references indexed in Scilit:
- The in-vitro activity of Bay y 3118, a new chlorofluoroquinoloneJournal of Antimicrobial Chemotherapy, 1993
- Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1992
- Lipopolysaccharide Alterations Responsible for Combined Quinolone and β-Lactam Resistance in Pseudomonas aeruginosaChemotherapy, 1992
- Cloning and characterization of a DNA fragment that complements the nfxB mutation in Pseudomonas aeruginosa PAOFEMS Microbiology Letters, 1991
- Broad-host-range gyrase A gene probeAntimicrobial Agents and Chemotherapy, 1990
- Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditisAntimicrobial Agents and Chemotherapy, 1989
- Mutations producing resistance to norfloxacin in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1987
- Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coliAntimicrobial Agents and Chemotherapy, 1986
- Cross-Resistance to Nalidixic Acid, Trimethoprim, and Chloramphenicol Associated with Alterations in Outer Membrane Proteins of Klebsiella, Enterobacter, and SerratiaThe Journal of Infectious Diseases, 1985
- Plasmid-mediated gentamicin resistance of Pseudomonas aeruginosa and its lack of expression in Escherichia coliAntimicrobial Agents and Chemotherapy, 1982